Vaccine News: Breaking Vaccine News, Comments and Articles. - Page: 3

Vaccine Administration

Do you administer vaccines in the target area of the deltoid? Or are your patients at risk for injury? Journal of the American Pharmacists Association

Immunizations in Adults Taking DMARDs

Which DMARDs can decrease vaccine efficacy or increase vaccine-associated risk? U.S. Pharmacist

Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth

NEW YORK, LONDON, BERLIN and PARIS, May 20, 2013 /PRNewswire/ -- Arthroscopy Devices Market to 2018 - Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Future Growth" looks at the market landscape, competitive landscape, and market trends for the six arthroscopy device market segments: arthroscopes, arthroscopy shavers, arthroscopy Fluid Management...

SAIC Awarded Contract By Joint Program Executive Office For Chemical And Biological Defense

MCLEAN, Va., May 20, 2013 /PRNewswire/ -- Science Applications International Corporation (SAIC) [NYSE: SAI] announced it was awarded a prime contract by the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) to provide program, engineering, medical, and technical support services. The multiple-award indefinite-delivery/indefinite quantity contract has a three-year b...

Why Feeling Anxious About a Vaccine Makes It More Effective (And Other Benefits of Short-Term Stress)

[caption id="attachment_761" align="alignleft" width="300" caption="Source: CDC, via Wikimeda Commons"] [/caption]SAN FRANCISCO--Standing at a podium in front of an audience of psychiatrists, clinicians and scientists, Firdaus Dhabhar brings up a...

New Kaiser Permanente study shows effectiveness of whole-cell pertussis vaccines

Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics.

Measles surges in UK years after vaccine scare

More than a decade ago, British parents refused to give measles shots to at least a million children because of a vaccine scare that raised the specter of autism. Now, health officials are scrambling to catch up and stop a growing epidemic of the con...

Newer whooping cough vaccine not as protective

NEW YORK (Reuters Health) - A newer version of the whooping cough vaccine doesn't protect kids as well as the original, which was phased out in the 1990s because of safety concerns, according to a new study.

Equatorial Guinea To Renovate All Its Hospitals Within Four Years

MALABO, Equatorial Guinea, May 17, 2013 /PRNewswire-USNewswire/ -- The government of Equatorial Guinea is working to renovate all the hospitals in the country within the next four years, according to Minister of Health Tomas Mecheba Fernandez Galilea. Mr. Fernandez, who is also secretary general of the Socialist Party of Equatorial Guinea (PSGE), discussed the renovation project in a press confe...

Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak

OAKLAND, Calif., May 20, 2013 /PRNewswire/ -- Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics. Whole-cell pertussis vaccines, also called DTwP, were available from the 1940s to 1990s, but were associated with safety conc...

Allied Healthcare Group shares ride high on back of strong prospects for its CardioCel product

Allied Healthcare Group (ASX:AHZ) shares jumped over 12% today as the market continued to recognise the prospects for its CardioCel product for the treatment of congenital heart disease and value within the group. The shares have gained almost 18%...

Newer Whooping Cough Vaccines Fall Flat (CME/CE)

(MedPage Today) -- Youngsters who received older whole-cell whooping cough vaccines had greater protection during a recent outbreak than those who got newer acellular medications, researchers reported.

Galileo: A TALL order

Galileo's allogeneic immunotherapy mimics natural killer cells, but they spare healthy cells and could have broader activity than off-the-shelf cancer vaccines in development.

Germ-fighting vaccine system makes great strides in delivery

(American Association of Pharmaceutical Scientists) A novel vaccine study from South Dakota State University will headline the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' National Biotechnol...

Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak

(Kaiser Permanente) Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics.

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

HIV Vaccine Trial Halted

Another HIV vaccine trial has been stopped early, after gay men given the vaccine were infected with the virus more than those given a placebo shot.

Why the Precautionary Principal is a Crock. Speed Matters when it comes to Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics

VACCINES Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics

Scottish Government advises healthcare workers to get MMR jab

Healthcare workers in Scotland are being urged to get vaccinated against measles in light of the continuing increased risk of infection across the country. The Scottish Government has written to frontline staff asking them to contact their occup...

Merck to Present at the UBS Global Healthcare Conference

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck, is scheduled to present at the UBS Global Healthcare Conference in New York City on May 20, 2013 at 10:30 a.m. EDT. Investors, analysts, members of the media and the general public are inv...

Going viral

IF A new and deadly strain of influenza were to arise, putting together a vaccine against it in the least possible time would be a priority. To test how quickly that could be done a group of researchers have just had a race with themselves. (The Econ...

News and press releases: European Medicines Agency recommends first vaccine for foot-and-mouth disease for authorisation at EU level

The European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) has recommended the marketing authorisation for Aftovaxpur DOE for use in response to outbreaks of foot-and-mouth disease (FMD).

Global Health, Development and Business Leaders Announce New Innovative Financing Partnership to Deliver Essential Health Supplies More Quickly and Efficiently

A New 5-year Guarantee Has the Potential to Unlock Immense Private Sector Financing, Accelerating Efforts to Achieve MDGs Today, leading global health and development experts from the public and private sectors are joining forces at the 2013 GBCHealth Conference to announce a new partnership that will leverage private sector funding to speed up deliver...

WHO Reports Coronavirus Sickens Two Saudi Healthcare Workers

Lawrence LeBlond for redOrbit.com - Your Universe Online The World Health Organization (WHO) on Wednesday announced it received confirmation from Saudi Arabia’s Ministry of Health that two healthcare workers in their country have become infected with the novel coronavirus (nCoV). The two new diagnoses occurred after exposure to patients with confirmed nCoV. The Ministry said the first patient...

First influenza vaccine brought to clinical testing

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on...